[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Age Related Macular Degeneration Drug Market Report 2017

January 2018 | 112 pages | ID: U148D8C824DEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Age Related Macular Degeneration Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Age Related Macular Degeneration Drug in these regions, from 2012 to 2022 (forecast).
United States Age Related Macular Degeneration Drug market competition by top manufacturers/players, with Age Related Macular Degeneration Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Applied Genetic Technologies Corp
  • Astellas Pharma Inc
  • Benitec Biopharma Ltd
  • Biokine Therapeutics Ltd
  • Crinetics Pharmaceuticals Inc
  • Critical Pharmaceuticals Ltd
  • Daiichi Sankyo Company Ltd
  • Diffusion Pharmaceuticals Inc
  • Dong-A Socio Holdings Co Ltd
  • Eleven Biotherapeutics Inc
  • Elsalys Biotech SAS
  • Lupin Ltd
  • M's Science Corp
  • Mabion SA
  • MacuCLEAR Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Lucentis
  • Eylea
  • Avastin
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Age Related Macular Degeneration Drug Market Report 2017

1 AGE RELATED MACULAR DEGENERATION DRUG OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug by Product Category
  1.2.1 United States Age Related Macular Degeneration Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Age Related Macular Degeneration Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Lucentis
  1.2.4 Eylea
  1.2.5 Avastin
  1.2.6 Others
1.3 United States Age Related Macular Degeneration Drug Market by Application/End Users
  1.3.1 United States Age Related Macular Degeneration Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Age Related Macular Degeneration Drug Market by Region
  1.4.1 United States Age Related Macular Degeneration Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Age Related Macular Degeneration Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Age Related Macular Degeneration Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Age Related Macular Degeneration Drug Status and Prospect (2012-2022)
  1.4.5 New England Age Related Macular Degeneration Drug Status and Prospect (2012-2022)
  1.4.6 The South Age Related Macular Degeneration Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Age Related Macular Degeneration Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Age Related Macular Degeneration Drug (2012-2022)
  1.5.1 United States Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Age Related Macular Degeneration Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Age Related Macular Degeneration Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Age Related Macular Degeneration Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Age Related Macular Degeneration Drug Market Competitive Situation and Trends
  2.4.1 United States Age Related Macular Degeneration Drug Market Concentration Rate
  2.4.2 United States Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Age Related Macular Degeneration Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Age Related Macular Degeneration Drug Sales and Market Share by Region (2012-2017)
3.2 United States Age Related Macular Degeneration Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Age Related Macular Degeneration Drug Price by Region (2012-2017)

4 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Age Related Macular Degeneration Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Age Related Macular Degeneration Drug Price by Type (2012-2017)
4.4 United States Age Related Macular Degeneration Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Age Related Macular Degeneration Drug Sales and Market Share by Application (2012-2017)
5.2 United States Age Related Macular Degeneration Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Applied Genetic Technologies Corp
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Astellas Pharma Inc
  6.2.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Benitec Biopharma Ltd
  6.3.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Biokine Therapeutics Ltd
  6.4.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Crinetics Pharmaceuticals Inc
  6.5.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Critical Pharmaceuticals Ltd
  6.6.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Daiichi Sankyo Company Ltd
  6.7.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Diffusion Pharmaceuticals Inc
  6.8.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dong-A Socio Holdings Co Ltd
  6.9.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Eleven Biotherapeutics Inc
  6.10.2 Age Related Macular Degeneration Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Elsalys Biotech SAS
6.12 Lupin Ltd
6.13 M's Science Corp
6.14 Mabion SA
6.15 MacuCLEAR Inc

7 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

7.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Age Related Macular Degeneration Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Age Related Macular Degeneration Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Age Related Macular Degeneration Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Age Related Macular Degeneration Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Age Related Macular Degeneration Drug
Figure United States Age Related Macular Degeneration Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Lucentis Product Picture
Figure Eylea Product Picture
Figure Avastin Product Picture
Figure Others Product Picture
Figure United States Age Related Macular Degeneration Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Age Related Macular Degeneration Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Age Related Macular Degeneration Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Age Related Macular Degeneration Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Age Related Macular Degeneration Drug Sales Share by Players/Suppliers
Figure 2017 United States Age Related Macular Degeneration Drug Sales Share by Players/Suppliers
Figure United States Age Related Macular Degeneration Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Age Related Macular Degeneration Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Age Related Macular Degeneration Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Age Related Macular Degeneration Drug Revenue Share by Players/Suppliers
Figure 2017 United States Age Related Macular Degeneration Drug Revenue Share by Players/Suppliers
Table United States Market Age Related Macular Degeneration Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Age Related Macular Degeneration Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Age Related Macular Degeneration Drug Market Share of Top 3 Players/Suppliers
Figure United States Age Related Macular Degeneration Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Age Related Macular Degeneration Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Age Related Macular Degeneration Drug Product Category
Table United States Age Related Macular Degeneration Drug Sales (K Pcs) by Region (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales Share by Region (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Share by Region (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Market Share by Region in 2016
Table United States Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Age Related Macular Degeneration Drug Revenue Share by Region (2012-2017)
Figure United States Age Related Macular Degeneration Drug Revenue Market Share by Region (2012-2017)
Figure United States Age Related Macular Degeneration Drug Revenue Market Share by Region in 2016
Table United States Age Related Macular Degeneration Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales (K Pcs) by Type (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales Share by Type (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Share by Type (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Market Share by Type in 2016
Table United States Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type in 2016
Table United States Age Related Macular Degeneration Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Growth Rate by Type (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales (K Pcs) by Application (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales Market Share by Application (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Market Share by Application (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Market Share by Application in 2016
Table United States Age Related Macular Degeneration Drug Sales Growth Rate by Application (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Growth Rate by Application (2012-2017)
Table Applied Genetic Technologies Corp Basic Information List
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Benitec Biopharma Ltd Basic Information List
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Biokine Therapeutics Ltd Basic Information List
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Crinetics Pharmaceuticals Inc Basic Information List
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Critical Pharmaceuticals Ltd Basic Information List
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Company Ltd Basic Information List
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Diffusion Pharmaceuticals Inc Basic Information List
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Dong-A Socio Holdings Co Ltd Basic Information List
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Eleven Biotherapeutics Inc Basic Information List
Table Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales Growth Rate (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales Market Share in United States (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Revenue Market Share in United States (2012-2017)
Table Elsalys Biotech SAS Basic Information List
Table Lupin Ltd Basic Information List
Table M's Science Corp Basic Information List
Table Mabion SA Basic Information List
Table MacuCLEAR Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Players/Suppliers in 2016
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Age Related Macular Degeneration Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Age Related Macular Degeneration Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Age Related Macular Degeneration Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories